BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26408402)

  • 1. Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.
    Seipel K; Marques MT; Bozzini MA; Meinken C; Mueller BU; Pabst T
    Clin Cancer Res; 2016 Feb; 22(3):746-56. PubMed ID: 26408402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
    Pabst T; Mueller BU
    Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review].
    Wang LM; Xiao HW; Huang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1256-60. PubMed ID: 23114160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 and CEBPA expression in acute myeloid leukemia.
    D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
    Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML.
    Jakobsen JS; Laursen LG; Schuster MB; Pundhir S; Schoof E; Ge Y; d'Altri T; Vitting-Seerup K; Rapin N; Gentil C; Jendholm J; Theilgaard-Mönch K; Reckzeh K; Bullinger L; Döhner K; Hokland P; Fitzgibbon J; Porse BT
    Sci Adv; 2019 Jul; 5(7):eaaw4304. PubMed ID: 31309149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML.
    Haefliger S; Klebig C; Schaubitzer K; Schardt J; Timchenko N; Mueller BU; Pabst T
    Blood; 2011 Jun; 117(22):5931-40. PubMed ID: 21471526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
    J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
    Guo H; Cooper S; Friedman AD
    PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
    Federzoni EA; Humbert M; Valk PJ; Behre G; Leibundgut EO; Torbett BE; Fey MF; Tschan MP
    Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
    [No Abstract]   [Full Text] [Related]  

  • 12. CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.
    Libura M; Pawełczyk M; Florek I; Matiakowska K; Jaźwiec B; Borg K; Solarska I; Zawada M; Czekalska S; Libura J; Salamanczuk Z; Jakóbczyk M; Mucha B; Duszeńko E; Soszyńska K; Karabin K; Piątkowska-Jakubas B; Całbecka M; Gajkowska-Kulig J; Gadomska G; Kiełbiński M; Ejduk A; Kata D; Grosicki S; Kyrcz-Krzemień S; Warzocha K; Kuliczkowski K; Skotnicki A; Jęrzejczak WW; Haus O
    Blood Cells Mol Dis; 2015 Dec; 55(4):284-92. PubMed ID: 26460249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the unfolded protein response in human acute myeloid leukemia.
    Schardt JA; Mueller BU; Pabst T
    Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia.
    Hughes JM; Salvatori B; Giorgi FM; Bozzoni I; Fatica A
    J Hematol Oncol; 2014 Sep; 7():69. PubMed ID: 25252716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evaluation of CEBPA gene mutation in normal karyotype acute myeloid leukemia: a comparison of two methods and report of novel CEBPA mutations from Indian acute myeloid leukemia patients.
    Ahmad F; Rajput S; Mandava S; Das BR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):707-15. PubMed ID: 22731647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia.
    Schardt JA; Eyholzer M; Timchenko NA; Mueller BU; Pabst T
    J Cell Mol Med; 2010 Jun; 14(6B):1509-19. PubMed ID: 19659458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation.
    Federzoni EA; Humbert M; Torbett BE; Behre G; Fey MF; Tschan MP
    Sci Rep; 2014 Mar; 4():4261. PubMed ID: 24584857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.
    Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM
    Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
    Pulikkan JA; Peramangalam PS; Dengler V; Ho PA; Preudhomme C; Meshinchi S; Christopeit M; Nibourel O; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
    Blood; 2010 Dec; 116(25):5638-49. PubMed ID: 20889924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.